Skip to main content

IIH Allegations On Mirena Dismissed For Lack Of Proof

IIH Allegations On Mirena Dismissed For Lack Of Proof

IIH Allegations On Mirena Dismissed For Lack Of Proof

Introduction

U.S. District Judge Paul Engelmayer passed a summary judgment motion in a suit that alleged Mirena causes idiopathic intracranial hypertension, or IIH, further stating clearly in the multidistrict litigation, Bayer AG cannot be held responsible for causing IIH as the plaintiffs failed to show there was any admissible evidence proving Mirena could cause IIH.

The ruling was a result of a lack of proof against the pharmaceutical giant. Around 920 women allege Mirena use caused them to develop Idiopathic Intracranial Hypertension (IIH), which if left untreated, can cause headaches, vision problems and, in extreme cases, blindness. The judge said there is no scientific literature reviewed by medical organization, regulator or peer that has found Mirena, or any contraceptive, to be a cause of IIH.

As per the statement released by Bayer, "Judge Engelmayer's decision on summary judgment is a significant ruling that dismisses all cases pending in the MDL." Three multidistrict litigations have been set-up covering alleged side-effects of Mirena IUDs: MDL No. 2434 (In Re: Mirena IUD Products Liability Litigation (uterine perforation and migration) assigned to U.S. District Judge Cathy Seibel/and Judge Brian R. Martinotti of the Bergen County Superior Court; MDL No. 2767 (In Re:Mirena IUD Levonorgestrel-Related Products Liability Litigation (NO. II) ) in the United States District Courts; and NJ MCL No. 297 in New Jersey State Courts.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!